期刊文献+

肝脏转运蛋白在药物肝胆转运中的作用

Important application of hepatic transporters on drug transport in liver and gall
下载PDF
导出
摘要 目的对肝脏转运蛋白在药物肝胆转运中的作用作一综述,为药物肝靶向提供依据。方法根据文献,从药物不良反应、药物的矢量转运、药物肝靶向性、药物之间相互作用4个方面阐述肝脏转运蛋白对药物肝胆排泄产生的影响。结果肝脏转运蛋白引起的药物矢量转运影响药物的肝脏摄取,药物肝靶向性影响药物的疗效,药物之间相互作用影响临床用药安全和不良反应。结论肝脏转运蛋白在药物肝胆转运中起到了重要的作用,它与药物在体内各组织分布、临床疗效均有密切的联系。 Objective To review the application of hepatic transporters on drug transport in liver and gall. Methods Based on the literatures, the important influence of hepatic transporters on drug absorption was discussed from four aspects:adverse drug responses, vectorial transport of drugs, hepatic target of drugs and drug-drug interactions. Results Hepatic transporters could influence drug therapeutic and adverse responses, and provide a good way for hepatic targeting. Conclusions Hepatic transporters have important effects on drug transport in liver and gall, and closely associate with drug distribution in vivo and clinical treatment.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2007年第10期653-658,共6页 Journal of Shenyang Pharmaceutical University
关键词 肝脏转运蛋白 药物吸收 药物转运 hepatic transporters drug absorption drug transport
  • 相关文献

参考文献12

  • 1KATHLEEN M,GIACOMINI,YUICHI S.Goodman & Gilman's the pharmacological basis of therapeutics[M].Tokyo:[s.n.],2004:58-64.
  • 2NAKAI D,NAKAGOMI R,FURUTA Y,et al.Human liver-specific organic anion transporter,LST-1,mediates uptake of pravastatin by human hepatocytes[J].J Pharmacol Exp Ther,2001,297 (3):861-865.
  • 3DOMINGUEZ M F,MACIAS R I,IZCO-BASURKO I,et al.Low in vivo toxicity of a novel cisplatinursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors[J].J Pharmacol Exp Ther,2001,297(3):1106-1108.
  • 4UEDA K,KATO Y,KOMATSU K,et al.Inhibition of biliary excretion of methotrexate by probenecid in rat:Quantitative prediction of interaction from in vitro data[J].J Pharmacol Exp Ther,2001,297(3):1036-1041.
  • 5VAVRICKA S R,VAN M J,HA H R,et al.Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver[J].Hepatology,2002,36 (1):164-167.
  • 6SHITARA Y,ITOH T,SATO H,et al.Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A[J].J Pharmacol Exp Ther,2003,304(2):610-613.
  • 7SHITARA Y,HIRANO M,ADACHI Y,et al.In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats[J].Drug Metab Dispos,2004,32(12):1468-1470.
  • 8SHITARA Y,HIRANO M,SATO H,et al.Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of ceribastatin:Analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil[J].J Pharmcol Exp Ther,2004,311 (1):228-230.
  • 9FATTINGER K,FUNK C,PANTZE M,et al.The endothelin antagonist bosentan inhibits the canalicular bile salt export pump:A potential mechanism for hepatic adverse reactions[J].Clin Pharmacol Ther,2001,69(4):223-227.
  • 10FUNK C,PANTZE M,JEHLE L,et al.Troglitazoneinduced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats.Correl in troglitazone sulfate formation and the inhitition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate[J].Toxicology,2001,167(1):83-85.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部